MoonLake Immunotherapeutics (MLTX) financials · $1.41B cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
MoonLake Immunotherapeutics (MLTX) $1.41B cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$244.8M | -$143.1M |
| Net Income | -$227.3M | -$118.9M |
| EPS (Diluted) | -$3.53 | -$1.89 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $424.4M | $477.9M |
| Current Assets | $421.7M | $474.3M |
| Cash & Equivalents | $334.5M | $180.4M |
| PP&E | $577.0K | $722.2K |
| Total Liabilities | $120.0M | $24.5M |
| Current Liabilities | $45.5M | $22.5M |
| Long-term Debt | $74.1M | N/A |
| Total Debt | $74.1M† | N/A |
| Shareholders' Equity | $304.5M | $446.8M |
| Retained Earnings | -$462.9M | -$235.6M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$196.0M | -$116.6M |
| CapEx | $35.0K | $519.5K |
| Investing Cash Flow | $203.0M | -$205.6M |
| Financing Cash Flow | $146.0M | $51.3M |
| Net Change in Cash | $154.1M | -$270.7M |
| Free Cash Flow | -$196.0M | -$117.1M |
FAQ
What is MLTX P/E and revenue?
MoonLake Immunotherapeutics (MLTX) $1.41B cap.
What is MLTX revenue?
MLTX income-statement cache has no revenue figure yet.
Is MLTX profitable?
MoonLake Immunotherapeutics last cached net income is -$227.3M (FY2025).
What are MLTX total assets?
MoonLake Immunotherapeutics last cached total assets are $424.4M (FY2025).
What is MLTX free cash flow?
MoonLake Immunotherapeutics last cached free cash flow is -$196.0M (FY2025).
Not investment advice. Cached statements, not a live tape.